The Death Of The Farm Bill Could Work Out For Marijuana Stocks
The big question for marijuana stock investors is how the market will react to the newly passed bill to reverse the 2018 Farm Bill. A new bill was recently passed with language that essentially overturned the Hemp laws in the USA. Many legal operators produced hemp and CBD products to ensure compliance under the bill as a way to energetically take part in the industry. Now, legal operators in legal states cultivating cannabis vs hemp have an entirely different legal road map to follow. Yet this is what many are calling a step backwards, and rightfully so.
Additionally, many believe this is the first significant step for the government to establish federal reform. This is a somewhat unbalanced scenario, where legal operators are now in the hands of the government even more than before. How will legal states proceed forward with more cultivar options and preserving cannabis genetics that make up the end product? For now, there is no clear path on what will take place other than the termination of the 2018 Farm Bill and the industry it created to some degree.
How this will impact marijuana stock trading and investing is yet to be determined. But for those wanting to see federal reform passed, putting the control into the hands of the government, like tobacco and alcohol, is how it typically goes. Nonetheless, legal cannabis is still here, and so are these top marijuana stocks to watch that could see a run if federal reform is passed.
Top Marijuana Stocks For Investors
- Aurora Cannabis Inc. (NASDAQ:ACB)
- Cronos Group Inc. (NASDAQ:CRON)
- SNDL Inc. (NASDAQ:SNDL)
Aurora Cannabis Inc.
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. Back on November 5th, the company reported its Fiscal 2026 Q2 results. 
Fiscal 2026 Second Quarter Highlights
- Expands YoY Global Medical Cannabis Net Revenue 1 by 15% to Record $70.5 million
- Increases International Medical Cannabis Net Revenue 1 by 22% to Record $42.7 million, with leadership positions across key markets
- Delivers Adjusted EBITDA1 growth of 52%, reaching $15.4 million
- Maintains Strong Balance Sheet with $141.9 million of Cash and Debt-Free Cannabis Business
[Read More] Cannabis Investing Insight: Here Is How To Invest In Marijuana Stocks
Cronos Group Inc.
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. The company has recently reported its Q2 2025 earnings.
Q2 2025 Financial Reports
- Achieved record levels of consolidated net revenue, gross profit and Adjusted EBITDA
- Net revenue in Q3 2025 increased by 9% quarter-over-quarter and 6% year-over-year
- Generated record-high net revenue in Israel, where PEACE NATURALS® remains the number one cannabis brand1
- Industry-leading balance sheet with $824 million in total cash and cash equivalents and short-term investments
[Read More] Three High-Potential Marijuana Stocks to Watch in a Volatile Market
SNDL Inc.
SNDL Inc. engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada. On November 4th, the company reported its financial and operational results for the third quarter. 
Q3 2026 Financial Results
- Net revenue: In the third quarter of 2025, net revenue totaled $244.2 million, reflecting a growth rate of +3.1%.
- Gross profit: Gross profit for the third quarter of 2025 reached $64.2 million, representing a +1.9% increase compared to the same period in the prior year.
- Gross margin (1): The gross margin in the third quarter of 2025 was 26.3%, reflecting a year-over-year decrease of -0.3 percentage points.
- Operating Income: The Company reported an operating loss of $(11.1) million in the third quarter of 2025.
- Cash flow: Cash flow was $32.4 million during the third quarter of 2025.
- Free cash flow (1): Free cash flow in the third quarter of 2025 reached a record $16.7 million, primarily driven by a reduction in working capital.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
